SLC6A3 and Parkinson disease: Particularly for Parkinsonian syndromes (PS), including Parkinson’s disease (PD), multiple system atrophy and progressive supranuclear palsy, characterized by degeneration of dopaminergic, nigro-striatal neurons, DAT is an excellent target for diagnostic imaging [3, 4].